ASCP Launches Advanced Analytics and Benchmarking Platform to Transform Laboratory Performance

New platform empowers healthcare organizations to transform laboratory metrics into actionable insights for better patient care.

CHICAGO, Sept. 26, 2025 /PRNewswire/ -- The American Society for Clinical Pathology (ASCP) has launched Performance and Diagnostics Insights (PDI), a groundbreaking platform designed to transform how healthcare organizations harness clinical and anatomic pathology laboratory data to assess performance and areas for improvement to elevate patient care.

PDI empowers laboratories and health systems with advanced benchmarking and quality performance insights, enabling them to measure, compare, and optimize laboratory operations, test utilization, and test quality. By providing access to aggregated and comparative analytics, PDI equips pathologists, laboratory professionals, and healthcare leaders with the actionable intelligence needed to improve clinical decision-making and ensure excellence in patient care.

"The laboratory influences nearly every patient diagnosis and treatment decision," says Alexandra Brown, MD, FASCP, Interim Chief Executive Officer of ASCP. "PDI equips healthcare organizations with the tools to transform laboratory metrics into meaningful insights that improve patient outcomes and set new standards for quality across pathology and laboratory medicine, and healthcare overall."

The platform's innovative design addresses one of the greatest challenges in laboratory medicine: scaling benchmarking and quality measurement across diverse institutions. PDI introduces robust, efficient solutions for data ingestion, transformation, and analysis, ensuring new laboratories can seamlessly onboard and contribute to a growing network of shared insights. The platform integrates seamlessly with existing Laboratory Information Systems (LIS) and Electronic Health Records (EHR) to capture data in real time. Built on a secure, HIPAA-compliant infrastructure, PDI incorporates advanced security protocols to protect patient data and ensure regulatory compliance.

"Laboratories are under unprecedented pressure to do more with fewer resources, while maintaining the highest standards of accuracy and compliance," says Sachin Gupta, PhD, MBA, MLS(ASCPⁱ)MBⁱ, LSSBB, CPHQ, Scientific Director of the Center for Quality and Patient Safety of ASCP. "This platform gives leaders the data-driven visibility they need to optimize operations, improve efficiency, turnaround times, and demonstrate value within their health systems and to patients."

By leveraging PDI, laboratories can:

• Benchmark their performance against national standards and peer institutions.
• Identify opportunities to optimize test utilization and laboratory efficiency.
• Translate quality metrics into actionable strategies for improving patient care.
• Strengthen the role of laboratory medicine in shaping clinical outcomes.

"PDI will fundamentally change how organizations think about their laboratory's value," says Dr. Brown. "It's not just about collecting data—it's about turning data into knowledge that drives better care for patients."

Performance and Diagnostics Insights is now available to healthcare organizations nationwide. To schedule a demonstration or request a consultation, visit www.ascpinsights.com or contact [email protected].

About ASCP
Founded in 1922 in Chicago, ASCP is a medical professional society with more than 100,000 member board-certified anatomic and clinical pathologists, pathology residents and fellows, laboratory professionals, and students. ASCP provides excellence in education, certification, and advocacy on behalf of patients, pathologists, and laboratory professionals. To learn more, visit http://www.ascp.org. Follow us on Twitter and connect with us on Facebook.

SOURCE American Society of Clinical Pathology